Oleuropein prevents the progression of steatohepatitis to hepatic fibrosis induced by a high-fat diet in mice
Tóm tắt
Từ khóa
Tài liệu tham khảo
Neuschwander-Tetri BA, Caldwell SH . Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202–1219.
Ong JP, Younossi ZM . Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007; 11: 1–16 vii.
Farrell GC, Larter CZ . Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99–S112.
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183–1192.
Larter CZ, Yeh MM . Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 2008; 23: 1635–1648.
Anstee QM . Animal models in nonalcoholic steatohepatitis research: utility and clinical translation. Liver Int 2011; 31: 440–442.
Bravo L . Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56: 317–333.
Te Sligte K, Bourass I, Sels JP, Driessen A, Stockbrugger RW, Koek GH . Non-alcoholic steatohepatitis: review of a growing medical problem. Eur J Intern Med 2004; 15: 10–21.
Cusi K . Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012; 142 (711-725): e6.
Oi-Kano Y, Kawada T, Watanabe T, Koyama F, Watanabe K, Senbongi R et al. Oleuropein, a phenolic compound in extra virgin olive oil, increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. J Nutr Sci Vitaminol (Tokyo) 2008; 54: 363–370.
Park S, Choi Y, Um SJ, Yoon SK, Park T . Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. J Hepatol 2011; 54: 984–993.
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313–1321.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M . Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 1994; 19: 1262–1271.
Anstee QM, Goldin RD . Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006; 87: 1–16.
Brown SD, Peters J . Combining mutagenesis and genomics in the mouse—closing the phenotype gap. Trends Genet 1996; 12: 433–435.
Ito M, Suzuki J, Tsujioka S, Sasaki M, Gomori A, Shirakura T et al. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol Res 2007; 37: 50–57.
Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL . Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig Dis Sci 2010; 55: 931–940.
Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373–379.
Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000; 95: 3584–3589.
Poudyal H, Campbell F, Brown L . Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 2010; 140: 946–953.